Clorox Company (The) (CLX) Lifted to “Outperform” at Consumer Edge

Consumer Edge upgraded shares of Clorox Company (The) (NYSE:CLX) from a neutral rating to an outperform rating in a research report released on Friday morning, Marketbeat.com reports.

A number of other analysts have also commented on CLX. Deutsche Bank AG reaffirmed a hold rating and issued a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. BidaskClub lowered Clorox Company (The) from a sell rating to a strong sell rating in a research report on Monday, July 24th. Zacks Investment Research lowered Clorox Company (The) from a buy rating to a hold rating in a research report on Monday, July 31st. Royal Bank Of Canada reaffirmed a hold rating and issued a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Finally, BMO Capital Markets set a $150.00 target price on Clorox Company (The) and gave the company a buy rating in a research report on Thursday, August 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of Hold and an average price target of $128.72.

Shares of Clorox Company (NYSE CLX) opened at $135.08 on Friday. Clorox Company has a 12-month low of $112.15 and a 12-month high of $141.76. The company has a market capitalization of $17,026.34, a PE ratio of 23.79, a P/E/G ratio of 3.60 and a beta of 0.39. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period in the previous year, the company posted $1.36 EPS. The firm’s revenue was up 4.0% compared to the same quarter last year. equities analysts anticipate that Clorox Company will post 5.58 earnings per share for the current fiscal year.

WARNING: “Clorox Company (The) (CLX) Lifted to “Outperform” at Consumer Edge” was originally reported by Stock Observer and is the property of of Stock Observer. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.thestockobserver.com/2017/11/14/clorox-company-the-clx-lifted-to-outperform-at-consumer-edge.html.

The business also recently declared a quarterly dividend, which was paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th were paid a dividend of $0.84 per share. The ex-dividend date of this dividend was Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a yield of 2.49%. Clorox Company (The)’s dividend payout ratio (DPR) is currently 61.88%.

In other news, SVP Matthew T. Laszlo sold 20,051 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the transaction, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Dawn C. Willoughby sold 2,158 shares of the business’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. Insiders have sold a total of 41,293 shares of company stock valued at $5,560,303 in the last quarter. Company insiders own 1.00% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Allianz Asset Management GmbH boosted its stake in shares of Clorox Company (The) by 417.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock worth $8,425,000 after buying an additional 51,534 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in shares of Clorox Company (The) by 2.8% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 67,918 shares of the company’s stock worth $8,959,000 after buying an additional 1,873 shares during the last quarter. Northeast Investment Management boosted its stake in shares of Clorox Company (The) by 2.2% in the 3rd quarter. Northeast Investment Management now owns 102,004 shares of the company’s stock worth $13,455,000 after buying an additional 2,183 shares during the last quarter. Private Advisor Group LLC boosted its stake in shares of Clorox Company (The) by 8.0% in the 3rd quarter. Private Advisor Group LLC now owns 26,363 shares of the company’s stock worth $3,373,000 after buying an additional 1,956 shares during the last quarter. Finally, Pinebridge Investments L.P. boosted its stake in shares of Clorox Company (The) by 16.8% in the 3rd quarter. Pinebridge Investments L.P. now owns 14,902 shares of the company’s stock worth $1,966,000 after buying an additional 2,144 shares during the last quarter. Hedge funds and other institutional investors own 71.58% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply